ReviewCureus2026

Switching Between Reference Adalimumab and Biosimilars in Adult Patients With Inflammatory Bowel Disease: A Systematic Literature Review.

Shuroog Nabhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.